2021
DOI: 10.1007/s11010-021-04219-w
|View full text |Cite
|
Sign up to set email alerts
|

Role of PI3K/Akt signaling pathway in cardiac fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
96
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 149 publications
(98 citation statements)
references
References 166 publications
2
96
0
Order By: Relevance
“…mirTarBase v8.0), the top three miRNA regulators of this gene network were hsa-mir-335-5p , hsa-mir-124-3p , and hsa-mir-26b-5p . Together with the hsa-mir-29b-3p and hsa-mir-29a-3p identified by gProfiler2, we mapped out these miRNAs on the gene-miRNA regulatory networks for the selected KEGG pathways relevant to the DMD-CO phenotypes: (1) Hypertrophy cardiomyopathy, (2) Dilated cardiomyopathy, (3) Arrhythmogenic right ventricular cardiomyopathy (ARVC), (4) PPAR signalling pathway (for adipogenesis), and (5) PI3K-Akt signalling pathway (for cardiac fibrosis (Qin et al, 2021)). The results showed that hypertrophy and dilated cardiomyopathy networks shared the same gene set (50 nodes, 49 edges), miRNA interactions ( Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…mirTarBase v8.0), the top three miRNA regulators of this gene network were hsa-mir-335-5p , hsa-mir-124-3p , and hsa-mir-26b-5p . Together with the hsa-mir-29b-3p and hsa-mir-29a-3p identified by gProfiler2, we mapped out these miRNAs on the gene-miRNA regulatory networks for the selected KEGG pathways relevant to the DMD-CO phenotypes: (1) Hypertrophy cardiomyopathy, (2) Dilated cardiomyopathy, (3) Arrhythmogenic right ventricular cardiomyopathy (ARVC), (4) PPAR signalling pathway (for adipogenesis), and (5) PI3K-Akt signalling pathway (for cardiac fibrosis (Qin et al, 2021)). The results showed that hypertrophy and dilated cardiomyopathy networks shared the same gene set (50 nodes, 49 edges), miRNA interactions ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Based on the duality effects of these miRNAs, the potential of these miRNAs as therapeutic targets for DMD-related cardiomyopathy need to be assessed carefully. Furthermore, the identified PI3K/Akt signaling pathway enriched in DMD-CO is interesting, as accumulating evidences showed that it plays a role in regulating the occurrence, progression and pathological cardiac fibrosis (Qin et al, 2021) and hypetrophy (Aoyagi and Matsui, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Fibrosis is a common process characterized by excessive ECM accumulation, whereas dynamic remodeling of the ECM around invasive cancer cells is implicated in tumor progression [ 57 ]. Accumulating evidence suggests that the PI3K/Akt signaling pathway plays a positive role in the pathological formation of fibrosis [ 58 ] and various human cancers [ 57 , 59 ]. In contrast, AMPK alleviates fibrogenesis and ECM production in various organs and tissues [ 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…A growing body of evidence delineates that the PI3K/AKT signaling pathway plays a key role in a multitude of processes related to the incidence, advancement, and pathological generation of cardiac fibrogenesis via the regulation of cell survival, apoptosis and cardiac contractility, albeit activating the target genes [ 100 , 116 , 117 , 118 ]. Essentially, the triggering of PI3K by receptor tyrosine kinases determines phosphorylation of phosphatidylinositol-4,5-bisphosphate (PIP2) to bring about phosphatidylinositol-3,4,5-triphosphate (PIP3) and activates the signaling pathway [ 119 ].…”
Section: Network Of Interactions Between Signaling Pathwaysmentioning
confidence: 99%
“…The activity of PI3K is counteracted by the tumor suppressor protein Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), which detaches the phosphate group from the 3′ end of the inositol ring of PIP3, thereby negatively regulating the pathway [ 119 , 120 ]. AKT kinase represents activated downstream of PIP3 and synchronizes miscellaneous downstream effectors, including the mammalian target of rapamycin (mTOR), GSK3B, and Forkhead box proteins O1/3 (FOXO1/3) [ 118 , 121 ]. Suppression of mTOR with rapamycin avoids cardiac hypertrophy, advocating that mTOR plays a pivotal role in cardioprotection [ 122 ].…”
Section: Network Of Interactions Between Signaling Pathwaysmentioning
confidence: 99%